Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 8750
Corporate User License Price USD 375
Corporate User License Price INR 26250
Site License Price USD 250
Site License Price INR 17500
Request a Quote

Report Title

Seattle Genetics Inc (SGEN)-Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Seattle Genetics Inc (SGEN)-Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Seattle Genetics Inc (SGEN)-Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Seattle Genetics Inc (SGEN)-Financial and Strategic SWOT Analysis Review



Executive Summary

Seattle Genetics Inc (SGEN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Seattle Genetics Inc (Seattle Genetics) is a biotechnology company that develops and commercializes monoclonal antibody-based therapies for the treatment of cancer. The company's lead product Adcetris (brentuximab vedotin) is an antibody-drug conjugate (ADC) indicated for the treatment of relapsed Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (sALCL). Seattle Genetics' product pipeline consists of ASG-22ME (enfortumab vedotin) for metastatic urothelial cancer. Its pipeline also comprises various antibody-drug conjugate (ADC) programs and immuno-oncology programs in various clinical stages of development. It uses ADC and sugar-engineered antibody (SEA) technologies for the development of its product portfolio. The company sells its products through pharmaceutical distributors and collaborators. Seattle Genetics is headquartered in Bothell, Washington, the US.

Seattle Genetics Inc Key Recent Developments

Feb 06,2018: Seattle Genetics Reports Fourth Quarter and Year 2017 Financial Results

Jan 08,2018: Seattle Genetics Highlights Leadership in Expanding Field of Antibody-Drug Conjugates (ADCs) at the 36th Annual J.P. Morgan Healthcare Conference

Dec 04,2017: Seattle Genetics COO Jumps Ship to Helm Biotech Startup Silverback Therapeutics

Oct 26,2017: Seattle Genetics Reports Third Quarter 2017 Financial Results

Jul 27,2017: Seattle Genetics Reports Second Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Seattle Genetics Inc-Key Facts

Seattle Genetics Inc-Key Employees

Seattle Genetics Inc-Key Employee Biographies

Seattle Genetics Inc-Major Products and Services

Seattle Genetics Inc-History

Seattle Genetics Inc-Company Statement

Seattle Genetics Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Seattle Genetics Inc-Business Description

Seattle Genetics Inc-Corporate Strategy

Seattle Genetics Inc-SWOT Analysis

SWOT Analysis-Overview

Seattle Genetics Inc-Strengths

Seattle Genetics Inc-Weaknesses

Seattle Genetics Inc-Opportunities

Seattle Genetics Inc-Threats

Seattle Genetics Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Seattle Genetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

Seattle Genetics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018

Seattle Genetics Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Feb 06, 2018: Seattle Genetics Reports Fourth Quarter and Year 2017 Financial Results

Jan 08, 2018: Seattle Genetics Highlights Leadership in Expanding Field of Antibody-Drug Conjugates (ADCs) at the 36th Annual J.P. Morgan Healthcare Conference

Dec 04, 2017: Seattle Genetics COO Jumps Ship to Helm Biotech Startup Silverback Therapeutics

Oct 26, 2017: Seattle Genetics Reports Third Quarter 2017 Financial Results

Jul 27, 2017: Seattle Genetics Reports Second Quarter 2017 Financial Results

Apr 27, 2017: Seattle Genetics Reports First Quarter 2017 Financial Results

Apr 03, 2017: Seattle Genetics Presents Data Advancing Antibody-Drug Conjugate and Novel Immuno-Oncology Programs at the American Association for Cancer Research Annual Meeting

Mar 30, 2017: Seattle Genetics Highlights Leadership in Antibody-Drug Conjugate Technology Innovation at the American Association for Cancer Research (AACR) Annual Meeting

Mar 30, 2017: Seattle Genetics Highlights Leadership in Antibody-Drug Conjugate Technology Innovation at the American Association for Cancer Research (AACR) Annual Meeting

Feb 09, 2017: Seattle Genetics Reports Fourth Quarter and Year 2016 Financial Results

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Seattle Genetics Inc, Performance Chart (2013-2017)

Seattle Genetics Inc, Ratio Charts

Seattle Genetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

Seattle Genetics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

List of Tables

Seattle Genetics Inc, Key Facts

Seattle Genetics Inc, Key Employees

Seattle Genetics Inc, Key Employee Biographies

Seattle Genetics Inc, Major Products and Services

Seattle Genetics Inc, History

Seattle Genetics Inc, Subsidiaries

Seattle Genetics Inc, Key Competitors

Seattle Genetics Inc, Ratios based on current share price

Seattle Genetics Inc, Annual Ratios

Seattle Genetics Inc, Annual Ratios (Cont...1)

Seattle Genetics Inc, Interim Ratios

Seattle Genetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

Seattle Genetics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018

Seattle Genetics Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person